Drugs / antacid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02097329 | Apr → Jun 2014 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | antacid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02097329 ↗ |
| Route | Oral | “30 mL orally once (2h before palbociclib)” NCT02097329 ↗ |